Related Experiment Video
Updated: Aug 15, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Biventricular assist device placement and immunosuppression as therapy for necrotizing eosinophilic myocarditis
Leslie T Cooper1, Kenton J Zehr
1Mayo Clinic College of Medicine, Rochester, MN 55905, USA. cooper.leslie@mayo.edu
Background:
A previously healthy 47-year-old woman presented reporting nausea, anorexia and light-headedness of 2 weeks' duration, and three episodes of syncope. She also had pleuritic chest pain and rapidly declining cardiac function. The only reported medical history was urinary tract infection and an ankle fracture sustained 5 months before presentation. She was receiving no medication other than estrogen patches for menopause and did not smoke or use illicit drugs.
Investigations:
Electrocardiography, chest radiography, echocardiography, measurement of creatinine phosphokinase and troponin T, coronary angiography and endomyocardial biopsy.
Diagnosis:
Necrotizing eosinophilic myocarditis.
Management:
Biventricular assist device implantation, methylprednisolone, prednisolone and mycophenolate mofetil.
Related Concept Videos
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
